Richard Steinhart
Directeur Financier/CFO chez BIOXCEL THERAPEUTICS, INC.
Fortune : 12 487 $ au 31/05/2024
Postes actifs de Richard Steinhart
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 08/11/2013 | - |
| Independent Dir/Board Member | 08/11/2013 | - | |
| ATOSSA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/03/2014 | - |
| Independent Dir/Board Member | 01/03/2014 | - | |
| BIOXCEL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/10/2017 | - |
| Directeur Financier/CFO | 01/10/2017 | - |
Historique de carrière de Richard Steinhart
Anciens postes connus de Richard Steinhart
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Directeur Financier/CFO | 14/10/2015 | 01/04/2017 |
| STRATA SKIN SCIENCES, INC. | Directeur Financier/CFO | 24/04/2006 | 31/12/2013 |
| Secrétaire Général | 24/04/2006 | 31/12/2013 | |
| Treasurer | 24/04/2006 | 31/12/2013 | |
| TG THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/07/2004 | 01/01/2012 |
| Independent Dir/Board Member | 27/06/2011 | 01/01/2012 | |
| Forest Street Capital, LLC | Corporate Officer/Principal | 01/05/1992 | 24/04/2006 |
| EMISPHERE TECHNOLOGIES, INC. | Directeur Financier/CFO | 01/05/1991 | 01/05/1992 |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Directeur Financier/CFO | 01/01/1991 | 02/01/1992 |
| ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░ ░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Formation de Richard Steinhart
| Pace University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 13 |
Opérationnelle
| Director of Finance/CFO | 6 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
Sectorielle
| Health Technology | 8 |
| Finance | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| STRATA SKIN SCIENCES, INC. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
CW Group, Inc.
CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Finance |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |
| Forest Street Capital, LLC | |
| SAE Ventures | |
| MELA Sciences Inc. |
- Bourse
- Insiders
- Richard Steinhart
- Expérience
